(Total Views: 811)
Posted On: 10/15/2020 1:18:53 AM
Post# of 153896
I'm still siding on a 60% chance for EUA as things are setting up for FDA to have some significant pressure:
1) The fall/winter increases predicted are starting and there is still a significant need for therapeutics.
2) FDA seems to be involved in the review.
3) Multiple vaccines have recently had safety issues, LL has had none so far.
4) Current analysis of data we know yields a reasonable chance to be close or exceed statistical significance.
Not overwhelming reasons but enough to push the chances on the positive side. Since ( or maybe 'if' ) the FDA is reviewing the data it does reduce the chance that we get outcome this week as this might add delays ( as pointed out by a few others here) so I'm preparing for about a 70% chance this week or 30% chance next week to hear the results.
Hopefully tomorrow though!
1) The fall/winter increases predicted are starting and there is still a significant need for therapeutics.
2) FDA seems to be involved in the review.
3) Multiple vaccines have recently had safety issues, LL has had none so far.
4) Current analysis of data we know yields a reasonable chance to be close or exceed statistical significance.
Not overwhelming reasons but enough to push the chances on the positive side. Since ( or maybe 'if' ) the FDA is reviewing the data it does reduce the chance that we get outcome this week as this might add delays ( as pointed out by a few others here) so I'm preparing for about a 70% chance this week or 30% chance next week to hear the results.
Hopefully tomorrow though!
(7)
(0)
